Anne A. Finucane
CIK 1511491 · last filed 2026-10-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WOONSOCKET, RI 02895
Holdings By Company
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| CVS | Direct | 591 | 2.6% | 2025-11-21 |
| By Trust | 22,156 | 97.4% | 2025-08-29 | |
| Total | 22,747 | |||
| No longer reported | ||||
| By Finucane Family Trust | 25,198 | — | last 2024-12-09 | |
10b5-1 Trading Plans
1 plan · 1 in force| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| WSM Director |
Jul 16, 2026 | Oct 14, 2026 | Dec 31, 2026 | 1,100 shares | 794 (72%) last filed Oct 16, 2026 |
Active | 10-Q |
Recent Filings · Page 3 of 7
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-29 | WSM | Grant (A) | — | $0 | EDGAR |
| 2024-07-31 | WSM | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | WSM | Mixed | +1,498 | $0 | EDGAR |
| 2024-05-17 | CVS | Grant (A) | — | $0 | EDGAR |
| 2024-05-01 | WSM | Grant (A) | — | $0 | EDGAR |
| 2024-01-30 | WSM | Grant (A) | +110 | $0 | EDGAR |
| 2023-12-08 | CVS | Gift (G) | −3,450 | -$256.3K | EDGAR |
| 2023-12-08 | WSM | Grant (A) | — | $0 | EDGAR |
| 2023-11-17 | CVS | Grant (A) | +1,925 | $133.1K | EDGAR |
| 2023-10-31 | WSM | Grant (A) | +145 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).